| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.049 | 0.8 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |